← Back to All Filings

NIKE Director Michelle Peluso Receives Routine Annual Equity Grant

Low SignificanceSeptember 10, 2026 at 9:38:43 PM UTC

NIKE, Inc.

$NKE4CIK: 0000320187

Subscribe to track NKE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

NIKE, Inc. ($NKE) Form 4 Filing Alert Insider: Michelle A. Peluso (Director) Action: Award / Grant (Code: A) Security: Class B Common Stock Shares Transacted: 5,047 @ $0.00 Total Value: $0.00 Post-Transaction Holdings: 37,861 shares Significance: Low (Routine annual director compensation grant)

Comprehensive Analysis

Executive Summary

On September 10, 2026, NIKE, Inc. ($NKE) filed a Form 4 reporting an equity award to Director Michelle A. Peluso. On September 8, 2026, Peluso was granted 5,047 shares of Class B Common Stock under the NIKE, Inc. Stock Incentive Plan at an exercise/acquisition price of $0.00 per share.

Transaction Breakdown

  • Insider: Michelle A. Peluso, Director
  • Transaction Code: A (Grant, award, or other acquisition pursuant to Rule 16b-3(d))
  • Shares Granted: 5,047 shares
  • Price Per Share: $0.00
  • Total Value: $0.00
  • Ownership Type: Direct
  • Vesting Terms: Restrictions lapse on 100% of the shares on the earlier of the next annual shareholder meeting or the last day of the 12th full calendar month following the grant date.
  • Post-Transaction Holdings: 37,861 shares

Market & Trading Significance

This transaction represents standard annual board equity compensation rather than open-market buying or selling activity. As a routine award with standard 1-year vesting restrictions, it does not convey directional sentiment or non-public operational outlook from leadership. Market significance is Low.

Topics:#NIKE#NKE#InsiderTrading#Form4#StockGrant

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.